Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.

Pharmaceutical

Stada Group

Peter Goldschmidt

Patrick Genestin

Christos Gallis

Stéphane Jacqmin

Boris Doebler

Simone Berger

Christoph Dengler

Bryan Kim

Miguel Pagan Fernandez

Stephan Eder

Volker Sydow

Frank Staud

Yann Brun

The Leadership Team at Stada Group is responsible for setting the strategic direction and vision of the company, guiding its operations across various pharmaceutical segments. Comprised of executives from key functional areas such as supply chain, development, finance, and marketing, the team collaborates to drive innovation, ensure regulatory compliance, and enhance brand presence in the healthcare market. Additionally, they focus on fostering a high-performance culture, optimizing operational efficiencies, and expanding into emerging markets to support the company’s growth objectives.

Leadership Team

Sales and Marketing

Research and Development

Leadership Team

About

Team members

Other teams at Stada Group

Sales and Marketing

Research and Development